Eli Lilly & Co. Stock Rises 6.6%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Eli Lilly & Co. rallied 6.6% to $1,373.70 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.3% to 7,720.39 and Dow Jones Industrial Average falling 0.3% to 52,342.56.

This was the stock's fourth consecutive day of gains.

Eli Lilly & Co. hit a new 52-week high, surpassing its previous peak of $1,321.21, which the company achieved on October 22nd.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.5% to $275.20, Pfizer Inc. rose 1.7% to $29.95, and AbbVie Inc. rose 1.68% to $290.79.

Trading volume totaled 4.3 million, compared to the 50-day average of 2.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 29, 2026 16:34 ET (20:34 GMT)